$INSM

$125.42▲ +4.5% YTD

6 SEC 13D/G filings tracked · Last updated Sep 21, 2026

Filing History

CP $125.42▲ +4.5%Sep 21, 2026 · ThinkSabio Blog

$INSM INSM - FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease Wit…

News

INSM ▲ +0.4% - Insmed Incorporated

CP $120.50▲ +0.4%Sep 16, 2026 · ThinkSabio Blog

$INSM INSM - Insmed Expands Community Impact During Fifth Annual Global Day of Good…

News

INSM ▼ -1.1% - Insmed Incorporated

CP $125.31▲ -1.1%Sep 4, 2026 · ThinkSabio Blog

$INSM INSM - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)…

News

INSM ▲ +0.2% - Insmed Incorporated

CP $126.90▲ +0.2%Sep 3, 2026 · ThinkSabio Blog

$INSM INSM - Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension)…

SEC 13D/G

INSM - Insmed Incorporated - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$130.90▼ -26.09%Aug 6, 2026 · ThinkSabio Blog

$INSM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #INSM Insmed Incorporated : $130.90 Sector: Healthcare | YTD: 🔽…

SEC 13D/G

$INSM SEC Filing Update (22-JUL-2026) | ThinkSabio - Stocks Simplified

$106.79▼ -39.70%Jul 22, 2026 · ThinkSabio Blog

$INSM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #INSM : $106.79 Sector: Healthcare | YTD: 🔽 -39.70% The SEC disc…